Gavi Endorses WHO-Prequalified RSV Maternal Vaccine to Avert Infant Pneumonia Deaths
A maternal vaccine protecting newborns against Respiratory Syncytial Virus (RSV) received WHO prequalification, marking a milestone in infant mortality prevention.
Geneva: Gavi welcomed WHO prequalification of the first multi-dose maternal vaccine combating RSV, the second-highest cause of infant mortality behind malaria.
Maternal immunization transmits protective antibodies transplacentally, defending babies throughout their first six critical months of life.
Yashika Women's Traditional Satin Butti Saree with Blouse Piece
About Pediatric Bureau
Pediatric Bureau is a senior correspondent at Greenline News covering health, Garhwa regional updates, and breaking news across Jharkhand.
View all articles by Pediatric BureauComments (2)
Excellent reporting on this issue. It's crucial that we stay informed about these developments.
Great coverage by Greenline News. Looking forward to further updates on Garhwa and Jharkhand developments.